Dosimetric Evaluation of Volumetric-Modulated Arc Therapy (RapidArc) for Primary Leiomyosarcoma in the Spine

This study aims to investigate the suitability of volumetric-modulated arc therapy (VMAT) with RapidArc for primary leiomyosarcoma (LMS) in the spine, and present a new method to improve the target coverage and organs at risk (OAR) sparing. Five patients with LMS were retrospectively reviewed. The intensity-modulated radiotherapy (IMRT) with five coplanar beams (5b-IMRT) or seven coplanar beams (7b-IMRT), and VMAT using four quasi-quarter coplanar arcs (4q-VMAT) or two full coplanar arcs (2f-VMAT) were generated. Planning target volume (PTV) dose coverage, OAR dose sparing, conformity index (CI), and homogeneity index (HI) were evaluated. A hollow-cylinder model (HCM) was also used for feasible optimal beam arrangements. The mean doses to PTV were 95.2% ± 1.0%, 93.0% ± 1.0%, 97.9% ± 1.0% and 96.2% ± 1.5% for 4q-VMAT, 2f-VMAT, 5b-IMRT and 7b-IMRT respectively, while the mean maximum doses to spinal cord (SC) were 43.7 ± 0.9 Gy, 42.0 ± 0.8 Gy, 41.4 ± 1.2 Gy and 40.6 ± 1.4 Gy. Compared to 5b-IMRT, the mean doses delivered to kidneys decreased by about 35.1% (8.5 Gy), 2.5% (0.6 Gy) and 35.5% (8.6 Gy) for 4q-VMAT, 2f-VMAT, and 7b-IMRT, respectively. The CI proposed by Baltas et al. was twice as good with IMRT than with 4q-VMAT, and the numbers of monitor units were increased five- and threefold with 7b-IMRT and with 5b-IMRT compared to VMAT. The unexpected results we presented here show that VMAT technique can't achieve highly conformal treatment plans while maintaining SC sparing for LMS in the spine. An approach is proposed based on a hollow-cylinder model, but it is difficult to apply to clinical practice. In this case, VMAT is not superior to IMRT except for significant reduction in delivery time.

[1]  P. Giraud,et al.  [Are there any dosimetric advantages in using VMAT for treatment of locally advanced non-small cell lung cancer?]. , 2012, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[2]  F. Jin,et al.  A novel correction factor based on extended volume to complement the conformity index. , 2012, The British journal of radiology.

[3]  Rajat J Kudchadker,et al.  A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment. , 2012, International journal of radiation oncology, biology, physics.

[4]  F. Lohr,et al.  A comparison of several modulated radiotherapy techniques for head and neck cancer and dosimetric validation of VMAT. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  T. Schultheiss,et al.  Radiation dose-volume effects in the spinal cord. , 2010, International journal of radiation oncology, biology, physics.

[6]  S. Bisht,et al.  Bilateral Renal Metastases In Oral Leiomyosarcoma: A Case Report , 2009 .

[7]  Fang-Fang Yin,et al.  Volumetric arc intensity-modulated therapy for spine body radiotherapy: comparison with static intensity-modulated treatment. , 2009, International journal of radiation oncology, biology, physics.

[8]  Lawrence B Marks,et al.  Integral dose conservation in radiotherapy. , 2009, Medical physics.

[9]  S. Bisht,et al.  Oral Leiomyosarcoma With Bilateral Renal Metastases In A Pregnant Female: A Case Report , 2008 .

[10]  S. Hee,et al.  Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience. , 2008, International journal of radiation oncology, biology, physics.

[11]  M. Sormani,et al.  Comparison of three strategies to delineate the bowel for whole pelvis IMRT of prostate cancer. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  Yosuke Watanabe,et al.  Metastatic leiomyosarcoma of the brain manifesting as multiple hemorrhages. Case report. , 2005, Neurologia medico-chirurgica.

[13]  P. Tsitsopoulos,et al.  Spinal manifestation of metastasizing leiomyosarcoma. , 1999, Spine.

[14]  D. Baltas,et al.  A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy. , 1998, International journal of radiation oncology, biology, physics.

[15]  M. Moerland,et al.  A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate. , 1997, International journal of radiation oncology, biology, physics.

[16]  T E Schultheiss,et al.  Radiation response of the central nervous system. , 1995, International journal of radiation oncology, biology, physics.

[17]  S. Shapiro,et al.  Myelopathy secondary to leiomyosarcoma of the spine. Case report. , 1992, Spine.

[18]  D. Paley,et al.  Leiomyosarcoma in bone: Primary or secondary? , 1983, Skeletal Radiology.

[19]  H. Suit,et al.  A clinical and pathological staging system for soft tissue sarcomas , 1977, Cancer.

[20]  P. Giraud,et al.  [Are there any dosimetric advantages in using VMAT for treatment of locally advanced non-small cell lung cancer?]. , 2012, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[21]  D. C. Henckel,et al.  Case report. , 1995, Journal.